Search results
New coalition voices water concerns in Laredo
KGNS Laredo TX· 11 hours agoA newly formed coalition is making waves in Laredo as they push for attention from city leaders amid ongoing discussions about the city’s water...
Novel CD40 Agonist-Chemo Combo Shows Promise in Pancreatic Cancer
MedPage Today· 2 days agoFrontline treatment with mitazalimab plus mFOLFIRINOX achieved responses in 40% of patients
Edmond may buy water from Oklahoma City, could impact dialysis machines and fish tanks
KOKH FOX 25· 4 days agoEdmond Water Resources may purchase water from Oklahoma City, which could impact home kidney...
Low Emission Rare Earth Metals Manufacturing From Domestic Sourced Minerals
Forbes· 6 days agoThe key competitive advantage of local mining and extraction is its ability to produce high-concentration intermediate sources in close proximity to raw minerals, like rare ...
Aphakic Kids' Secondary Lens Implants Pose Risks
Medscape· 1 day agoImplantation of a secondary intraocular lens in children with aphakic eye was associated with complications, refractive errors, and suboptimal visual...
Edmond advises residents of possible OKC water purchase
KFOR articles via Yahoo News· 3 days agoEdmond Water Resources wants to inform residents who use home kidney dialysis machines could have to...
Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer
MedPage Today· 2 days agoThe antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) significantly improved...
Triplet Notches Survival Win in Heavily Pretreated DLBCL
MedPage Today· 2 days agoBenefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant
AKRO INVESTOR ALERT: Kirby McInerney LLP Notifies Akero Therapeutics, Inc. (AKRO) Investors of...
Morningstar· 19 hours agoThe law firm of Kirby McInerney LLP reminds investors of the June 25, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed on behalf of those ...
Sunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer...
The Pilot News· 2 days agoThe global pivotal WU-KONG1B study investigating sunvozertinib achieved its primary objective with a manageable safety profile in relapsed or refractory NSCLC with EGFR exon20ins ...